Health behaviors of head and neck cancer patients the first year after diagnosis

Duffy, Sonia A.; Khan, Mohammad Javed; Ronis, David L.; Fowler, Karen E.; Gruber, Stephen B.; Wolf, Gregory T.; Terrell, Jeffrey E.

doi:10.1002/hed.20665

Cited by 71 publications

(81 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These changes in food consumption resulted in decreased energy intake, as shown in previous studies,12, 20, 25, 26 but also in poorer micronutrient and fiber intakes. Only 3 studies quantified nutrient intake variations between before and after diagnosis 20, 22, 27.…”

Section: Discussionsupporting

confidence: 73%

“…Dietary and alcohol intakes of cancer survivors have received increasing attention in the last decade 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29. Overall, these studies tended to suggest an improvement in dietary behavior after cancer diagnosis, as well as a strong motivation of cancer survivors to make lifestyle changes 4.…”

Section: Introductionmentioning

confidence: 99%

“…Overall, these studies tended to suggest an improvement in dietary behavior after cancer diagnosis, as well as a strong motivation of cancer survivors to make lifestyle changes 4. However, most of these studies were cross‐sectional and either compared survivors to cancer‐free subjects11, 13, 15, 16, 17, 18, 21, 26 or described only postdiagnosis dietary and alcohol intakes in cancer survivors 10, 12, 14, 19, 23. Although a few studies provided information on the variation of dietary and/or alcohol intakes between before and after cancer diagnosis,20, 22, 24, 25, 27, 28, 29 they reported retrospective or qualitative self‐reported changes, that are possibly prone to recall bias.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Modifications in dietary and alcohol intakes between before and after cancer diagnosis: Results from the prospective population-based NutriNet-Santé cohort

et al. 2017

View full text Add to dashboard Cite

Postdiagnosis diet and alcohol consumption may be associated with cancer prognosis, recurrence and mortality. Our aim was to investigate food, nutrient and alcohol intake variations between before and after cancer diagnosis and their determinants in a prospective cohort. Subjects (n = 696) were incident cancer cases diagnosed in the NutriNet‐Santé cohort between 2009 and 2016. Food, nutrient and alcohol intakes were prospectively collected using repeated nonconsecutive 24‐hr dietary records since subjects' inclusion (i.e. an average of 2 y before diagnosis). Mean number of dietary records per subject was 5.9 before and 8.1 after diagnosis. All dietary data before and after diagnosis were compared by mixed models. Factors associated with the main dietary changes observed were also investigated using multivariable logistic regressions. We observed a decrease in intakes of vegetables (mean decrease in intake in patients who decreased their intake=‐102.4 ± 79.8 g/d), dairy products (–93.9 ± 82.8 g/d), meat/offal (–35.5 ± 27.8/d), soy products (–85.8 ± 104.1 g/d), sweetened soft drinks (–77.9 ± 95.4 g/d), and alcoholic drinks (–92.9 ± 119.9 g/d), and an increase in broths (42.1 ± 34.9 g/d) and fats/sauces (18.0 ± 13.4 g/d). We observed a decrease in energy intake (–377.2 ± 243.5 kcal/d) and in intakes of alcohol (–7.6 ± 9.4 g/d) proteins (–17.4 ± 12.5 g/d), and several vitamins (p < 0.05) and micronutrients (p < 0.05). Conversely, lipid (19.4 ± 14.6 g/d), SFA (9.3 ± 7.0 g/d), MUFA (8.3 ± 6.3 g/d) and vitamin E (3.9 ± 3.3 mg/d) intakes increased after diagnosis. This large prospective study suggests that cancer diagnosis is a key period for nutritional changes. It highlights some healthy behaviors such as a decrease in alcohol and sweetened drink consumption, but also less favorable trends, such as a decrease in vegetable consumption and in many vitamin and mineral intakes. These results provide insights to identify and target recommendations to put forward for better nutritional care of cancer survivors.

show abstract

Section: Discussionsupporting

confidence: 73%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Modifications in dietary and alcohol intakes between before and after cancer diagnosis: Results from the prospective population-based NutriNet-Santé cohort

et al. 2017

View full text Add to dashboard Cite

show abstract

“…1 While cancer diagnosis and treatment can provide a "teachable moment" for smoking cessation, 2 more than half of cancer patients who smoked prior to diagnosis fail to stop smoking or relapse after their diagnosis. [3][4][5] Continued smoking following diagnosis is associated with decreased response to radiotherapy and chemotherapy, impaired wound healing, increased infections and circulatory problems, and late complications (eg, severe fibrosis, dysphagia). [5][6][7][8][9][10][11] Conversely, smoking cessation after diagnosis shows several medical benefits, such as decreased fatigue and shortness of breath, increased activity level and quality of life, and improved treatment toxicity.…”

Section: Introductionmentioning

confidence: 99%

Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?

Choi

Terrell

Bradford

et al. 2016

NICTOB

Self Cite

View full text Add to dashboard Cite

Introduction: To determine if smoking after a cancer diagnosis makes a difference in mortality among newly diagnosed head and neck cancer patients. Methods: Longitudinal data were collected from newly diagnosed head and neck cancer patients with a median follow-up time of 1627 days (N = 590). Mortality was censored at 8 years or September 1, 2011, whichever came first. Based on smoking status, all patients were categorized into four groups: continuing smokers, quitters, former smokers, or never-smokers. A broad range of covariates were included in the analyses. Kaplan-Meier curves, bivariate and multivariate Cox proportional hazards models were constructed. Results: Eight-year overall mortality and cancer-specific mortality were 40.5% (239/590) and 25.4% (150/590), respectively. Smoking status after a cancer diagnosis predicted overall mortality and cancer-specific mortality. Compared to never-smokers, continuing smokers had the highest hazard ratio (HR) of dying from all causes (HR = 2.71, 95% confidence interval [CI] = 1.48-4.98). Those who smoked at diagnosis, but quit and did not relapse-quitters-had an improved hazard ratio of dying (HR = 2.38, 95% CI = 1.29-4.36) and former smokers at diagnosis with no relapse after diagnosis-former smokers-had the lowest hazard ratio of dying from all causes (HR = 1.68, 95% CI = 1.12-2.56). Similarly, quitters had a slightly higher hazard ratio of dying from cancer-specific reasons (HR = 2.38, 95% CI = 1.13-5.01) than never-smokers, which was similar to current smokers (HR = 2.07, 95% CI = 0.96-4.47), followed by former smokers (HR = 1.70, 95% CI = 1.00-2.89). Conclusions: Compared to never-smokers, continuing smokers have the highest HR of overall mortality followed by quitters and former smokers, which indicates that smoking cessation, even after a cancer diagnosis, may improve overall mortality among newly diagnosed head and neck cancer patients. Health care providers should consider incorporating smoking cessation interventions into standard cancer treatment to improve survival among this population. Implications: Using prospective observational longitudinal data from 590 head and neck cancer patients, this study showed that continuing smokers have the highest overall mortality relative to never-smokers, which indicates that smoking cessation, even after a cancer diagnosis, may have beneficial effects on long-term overall mortality. Health care providers should consider incorporating smoking cessation interventions into standard cancer treatment to improve survival among this population.

show abstract

“…[3][4][5] Estimates suggest that between 35% and 62% of cancer patients continue smoking in the year after diagnosis. [6][7][8][9][10][11] A cancer diagnosis motivates patients to attempt to quit smoking. 12 Physicians can improve motivation and the likelihood of achieving abstinence by offering assistance, including giving advice and prescribing medication.…”

Section: Introductionmentioning

confidence: 99%

Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer

et al. 2017

View full text Add to dashboard Cite

PURPOSE Smoking cessation after a diagnosis of lung, bladder, and upper aerodigestive tract cancer appears to improve survival, and support to quit would improve cessation. The aims of this study were to assess how often general practitioners provide active smoking cessation support for these patients and whether physician behavior is influenced by incentive payments. METHODSUsing electronic primary care records from the UK Clinical Practice Research Datalink, 12,393 patients with incident cases of cancer diagnosed between 1999 and 2013 were matched 1 to 1 to patients with incident cases of coronary heart disease (CHD) diagnosed during the same time. We assessed differences in the proportion for whom physicians updated smoking status, advised quitting, and prescribed cessation medications, as well as the proportion of patients who stopped smoking within a year of diagnosis. We further examined whether any differences arose because the physicians were offered incentives to address smoking in patients with CHD and not cancer. RESULTSAt diagnosis, 32.0% of patients with cancer and 18.2% of patients with CHD smoked tobacco. Patients with cancer were less likely than patients with CHD to have their general practitioners update smoking status (OR = 0.18; 95% CI, 0.17-0.19), advise quitting (OR = 0.38; 95% CI, 0.36-0.40), or prescribe medication (OR = 0.67; 95% CI, 0.63-0.73), and they were less likely to have stopped smoking (OR = 0.76; 95% CI, 0.69-0.84). One year later 61.7% of patients with cancer and 55.4% with CHD who were smoking at diagnosis were still smoking. Introducing incentive payments was associated with more frequent interventions, but not for patients with CHD specifically.CONCLUSIONS General practitioners were less likely to support smoking cessation in patients with cancer than with CHD, and patients with cancer were less likely to stop smoking. This finding is not due to the difference in incentive payments. 2017;15:443-450. https://doi Ann Fam Med

show abstract

Health behaviors of head and neck cancer patients the first year after diagnosis

Cited by 71 publications

References 49 publications

Modifications in dietary and alcohol intakes between before and after cancer diagnosis: Results from the prospective population-based NutriNet-Santé cohort

Modifications in dietary and alcohol intakes between before and after cancer diagnosis: Results from the prospective population-based NutriNet-Santé cohort

Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?

Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer

Contact Info

Product

Resources

About